Federal judge overturns Purdue Pharma bankruptcy deal over Sackler family liability shield

OxyContin pills
(Image credit: AP Photo/Toby Talbot, File)

A federal judge in New York late Thursday threw out Purdue Pharma's bankruptcy settlement, ruling that federal bankruptcy law does not allow for the provision that shielded members of the Sackler family, who own Perdue but are not declaring bankruptcy themselves, from all lawsuits tied to their opioid drug OxyContin. The ruling by U.S. District Judge Colleen McMahon upends the complicated bankruptcy deal and raises new doubts about the future of Perdue, the Sacklers, and the funds from the deal that were earmarked for communities grappling with the opioid epidemic.

U.S. Bankruptcy Court Judge Robert D. Drain had approved the settlement in September, with buy-in from most of Purdue's creditors but opposed by nine states, the Justice Department's Bankruptcy Trustees office, and other critics. McMahon ruled Thursday that U.S. bankruptcy law does not allow Drain to release the Sacklers from current and future opioid lawsuits.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Explore More
Peter Weber, The Week US

Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.